Samsung Electronics Co., Ltd.

Osong Medical Innovation Foundation, Korea University Research and Business Foundation

Posco

Postech Foundation

Genexine, Inc.

Dong-a Pharm. Co., Ltd.

Daewood Co., Ltd.

Su-hyung Park

Jaeseok Park

Jin-Young Hwang

Young Chul Sung

Sang-cheon Choi

Yeol-min Seong

Chang Geun Lee

Jin-Won Youn

Se-Hwan Yang

A magnetic resonance imaging (MRI) apparatus and method are provided. The MRI apparatus includes a first interpolator configured to generate a plurality of first interpolation data by performing calibration on a plurality of undersampled K-space data obtained from a plurality of channel coils in a radio frequency (RF) multi-coil, respectively, and a second interpolator configured to generate a plurality of second interpolation data by performing calibration on a plurality of filtered data obtained by filtering the first interpolation data using a plurality of high-pass filters.

Magnetic resonance imaging apparatus and method

A method of generating a magnetic resonance image includes: generating composite data by using a plurality of data sets acquired from a plurality of coils, based on coil characteristics of the plurality of coils; generating first interpolation data by interpolating the composite data; generating a plurality of filtered data sets by filtering the first interpolation data with respect to a plurality of frequency bands; and generating the magnetic resonance image by using the plurality of filtered data sets.

Method and apparatus for generating magnetic resonance image

A method of generating a magnetic resonance image includes: generating pieces of first interpolation data by interpolating pieces of data obtained from each of the plurality of coils; generating pieces of weighted data by weighting the pieces of first interpolation data with respect to a plurality of frequency bands; and obtaining the magnetic resonance image corresponding to a subject by using the pieces of weighted data.

The present invention relates to a vaccine enhancing the protective immunity to Hepatitis C virus using plasmid DNA and recombinant adenovirus, more particularly to a vaccine consisting of &#x394; core-E1-E2 expressing DNA vaccine, nonstructural protein NS3 and NS4 expressing DNA vaccine, nonstructural protein NS5 expressing DNA vaccine and recombinant adenovirus vaccine, and method for administration of the vaccine by priming with the DNA vaccines described above and boosting with the recombinant adenovirus vaccine thereby enhancing the protective immunity to Hepatitis C virus.

Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus

Growing community of inventors

Seoul, South Korea

Su-hyung Park